SCHA vs XBI
Schwab US Small-Cap ETF vs SPDR S&P Biotech ETF
- • SCHA has the lower expense ratio at 0.03% vs 0.35% for XBI.
- • SCHA pays a higher dividend yield (0.99%).
Side-by-side metrics
| Metric | SCHA | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.03% | 0.35% |
Dividend yield Trailing 12-month yield. | 0.99% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $24.16B | $10.73B |
YTD return | 20.97% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.21 | 1.10 |
P/E ratio | 20.51 | — |
Last price | $35.16 | $164.01 |
Inception | — | — |
Issuer | Schwab | State Street |
SCHA top holdings
| SNDK | SanDisk Corp Ordinary Shares | 6.02% |
| LITE | Lumentum Holdings Inc | 1.31% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 0.76% |
| MKSI | MKS Inc | 0.56% |
| ATI | ATI Inc | 0.53% |
| STRL | Sterling Infrastructure Inc | 0.49% |
| MTSI | MACOM Technology Solutions Holdings Inc | 0.48% |
| GH | Guardant Health Inc | 0.40% |
| TTMI | TTM Technologies Inc | 0.38% |
| ONTO | Onto Innovation Inc | 0.35% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About SCHA
SCHA (Schwab US Small-Cap ETF) is US small-cap equities. Managed by Schwab, the fund carries $24.2B in assets under management, an expense ratio of 0.03%, a dividend yield of 0.99%. Its largest holding is SanDisk Corp Ordinary Shares (SNDK), which represents 6.0% of the portfolio. Real Estate is the fund's largest sector exposure at 6.2%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.